Blood Test Detects Alzheimer's Proteins Decades Before Symptoms in 86 Participants
Updated
Updated · ground.news · May 30
Blood Test Detects Alzheimer's Proteins Decades Before Symptoms in 86 Participants
14 articles · Updated · ground.news · May 30
Higher biomarker levels in 86 participants were linked to poorer memory and faster cognitive decline, suggesting Alzheimer’s-related changes can be detected long before symptoms emerge.
A simple blood test measured the hallmark proteins associated with Alzheimer’s, and researchers said the findings indicate the disease may already be present in midlife.
Experts said earlier blood-based detection could be highly valuable, though they cautioned that more research is needed before the approach can be widely used.
The study adds to efforts to identify Alzheimer’s earlier, when brain changes may begin decades before the condition becomes clinically apparent.
With tests now predicting Alzheimer's decades early, how can we manage the disease when a cure remains out of reach?
Could fixing cellular 'protein traffic jams' be the key to stopping Alzheimer's before the first symptom even appears?
From PET Scans to Blood Tests: The 2025 FDA-Approved Shift in Alzheimer’s Early Detection
Overview
In 2025, the FDA approved blood tests for Alzheimer's disease, marking a major breakthrough in early detection. These tests, such as the Elecsys pTau181, identify specific biomarkers in the blood that signal Alzheimer's pathology. With high accuracy, they are mainly used as an initial step to rule out the disease or to decide if more definitive tests, like PET scans or spinal fluid analysis, are needed. This tiered approach, supported by the Alzheimer’s Association, makes diagnosis less invasive and more accessible, allowing for earlier intervention and better management of Alzheimer’s disease.